ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0764

An Atypical ClassRheum: RheumMadness, a Collaborative Rheumatology Competition Building Knowledge and Community

Meridith Balbach1, Sabahat Usmani2, Guy Katz3, Lauren He4, Michael Macklin4, Iman Qaiser5, John Kellogg6, Courtney Bair6, Benjamin Lueck6, Akrithi Garren7, Matthew Sparks6, Lisa Criscione-Schreiber6 and David Leverenz6, 1Vanderbilt University Medical Center, Nashville, TN, 2Weiss Memorial Hospital, Chicago, IL, 3Massachusetts General Hospital, Boston, MA, 4University of Chicago, Chicago, IL, 5Louisiana State University, Shreveport, LA, 6Duke University School of Medicine, Durham, NC, 7MedStar/Georgetown Washington Hospital Center, Silver Spring, MD

Meeting: ACR Convergence 2023

Keywords: education, medical, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: Professional Education

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: To evaluate the evolving impact of RheumMadness, an online educational tournament of competing rheumatology concepts, over three years by describing changes in participant engagement, learner experience via the Community of Inquiry (CoI) framework, and incorporation of RheumMadness into local programs.

Methods: RheumMadness 2021, 2022, and 2023 presented single-elimination brackets of 16, 16, and 22 concepts, respectively, represented by scouting reports written by volunteer groups. During the 2021 and 2022 seasons the RheumMadness leadership team selected the concepts, whereas in 2023, authors selected the concepts. Participants submitted brackets predicting matchup outcomes, listened to the RheumMadness podcast, and discussed concepts on social media. Web-based analytics tracked engagement. A Qualtrics survey was distributed each year to assess self-reported engagement and CoI presences. The 2023 survey asked additional questions about incorporation of RheumMadness content into local programs. Prism v.9.3.1 was used to analyze normalized and non-normalized data with one-way ANOVA and the Kruskal-Wallis test by ranks, respectively.

Results: Participation increased annually from 105 bracket submissions in 2021 to 142 in 2023 (Table 1). Similarly, the number of authors contributing to a scouting report grew from 52 in 2021 to 123 in 2023. Scouting report views grew from 92 per report in 2021 to 130 per report in 2023, and over 60% of participants reported reading at least half of the scouting reports all three years. Despite an increase in direct metrics of social media engagement (users, posts, and engagements) from 2021 to 2023, there was a non-significant decrease in self-reported reading (p= 0.7531) or posting (p= 0.2560) related content on social media. Across all three years, over half of respondents agreed or strongly agreed with CoI prompts related to each cognitive, social, and teaching subdomain (Figure 1). Within the cognitive presence, there was a significant increase in knowledge integration in 2023 versus prior years (p= 0.04). Other subdomains did not change significantly over time. In 2023, 26/56 (46%) of respondents reported that their local training program incorporated RheumMadness content in some way, primarily by creating a scouting report. Some programs also reviewed RheumMadness content in a didactic session, hosted a journal club, or created quizzes (Figure 2). Further curricular integration at the undergraduate and graduate medical education may be warranted, as RheumMadness increased interest in rheumatology for 23/26 (88%) medical student and resident respondents.

Conclusion: Growth in engagement metrics and stable positive self-reported CoI experience suggests that RheumMadness continues to foster an online rheumatology community of learning. Enhanced knowledge integration in 2023 suggests effective improvement efforts, such as team selection by scouting report authors. Incorporation of RheumMadness content into rheumatology training programs and positive impact on early trainees indicates utility as an educational and recruitment tool, with opportunity for expansion as a novel curricular element for graduate and continuing medical education alike.

Supporting image 1

Table 1: Direct and self-reported participant characteristics and engagement with each curricular element in RheumMadness. Direct metrics (left columns) are derived from bracket and scouting report submissions, Google Analytics, Buzzsprout.com, and Keyhole as indicated. Self-reported data are derived from a survey distributed via social media, newsletter, and email.

* Direct metrics of participant training level and country of residence are not available for 2021.
† Data from Google Analytics from the time the reports were posted until tournament completion each year of the tournament. Scouting report views are not available in 2022 as the reports were hosted on an external website.
‡ Data from Buzzsprout.com hosting service from July through April each season.
§ Data from Keyhole.co, measuring engagement (primarily on Twitter) with the hashtag #RheumMadness from January through April of each tournament year.

Supporting image 2

Figure 1: Changes in agreement with Community of Inquiry (CoI) presences across time. Participant responses to four* cognitive, three social, and three teaching presences (written in italics) on a 1-5 point Likert scale during the 2021, 2022, and 2023 seasons. The proportion of respondents selecting a given level of agreement are represented by size of colored bar. Group averages by year were compared using one-way ANOVA or the Kruskal-Wallis test by ranks for normalized or non-normalized data, respectively, with p values represented below corresponding graph.

*The triggering presence (I can apply the knowledge created in RheumMadness to my work or other activities) was omitted from representation of cognitive presences due to space; participants demonstrated stable (p= 0.7075) agreement.

Supporting image 3

Figure 2. Incorporation of RheumMadness into fellowship or other training program amongst 56 survey respondents in 2023. Respondents could select more than one response option. Illustrative tweets demonstrating incorporation of #RheumMadness were selected by the leadership team.

*Percent reflects the proportion of all respondents (n= 56) selecting a response.


Disclosures: M. Balbach: None; S. Usmani: None; G. Katz: None; L. He: None; M. Macklin: None; I. Qaiser: None; J. Kellogg: None; C. Bair: None; B. Lueck: None; A. Garren: None; M. Sparks: None; L. Criscione-Schreiber: GlaxoSmithKlein(GSK), 5, UCB, 5; D. Leverenz: Pfizer, 5, Rheumatology Research Foundation, 5, Sanofi, 2.

To cite this abstract in AMA style:

Balbach M, Usmani S, Katz G, He L, Macklin M, Qaiser I, Kellogg J, Bair C, Lueck B, Garren A, Sparks M, Criscione-Schreiber L, Leverenz D. An Atypical ClassRheum: RheumMadness, a Collaborative Rheumatology Competition Building Knowledge and Community [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/an-atypical-classrheum-rheummadness-a-collaborative-rheumatology-competition-building-knowledge-and-community/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-atypical-classrheum-rheummadness-a-collaborative-rheumatology-competition-building-knowledge-and-community/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology